p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. Five hundred fifty-one patients with locally advanced, locoregionally ...
Ribociclib 200mg; with letrozole 2.5mg; tabs. Store refrigerated at 2°C to 8°C (36°F to 46°F). Excursions permitted between 2°C and 15°C (36°F and 59°F). After dispensing, patients may store at room ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S ...
TOKYO, January 6, 2016 - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Chugai and Novartis Pharma K.K. have agreed to terminate the agreement regarding co-marketing of aromatase ...
Co announces it has received tentative approval from the FDA for its Abbreviated New Drug Application for Letrozole Tablets U.S.P, 2.5 mg.
PITTSBURGH, April 25, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously ...
Lannett Company announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets, the generic version of Novartis‘ ...
A phase 2 study showed that progression-free survival was longer with palbociclib plus letrozole than with letrozole alone in the initial treatment of postmenopausal women with estrogen-receptor ...
In a previous analysis of this phase 3 trial, first-line ribociclib plus letrozole resulted in significantly longer progression-free survival than letrozole alone among postmenopausal patients with ...
Mortality Associated With Irinotecan Plus Bolus Fluorouracil/Leucovorin: Summary Findings of an Independent Panel PURPOSE: Expression of ErbB-1 and ErbB-2 (epidermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results